CINV Existing and Pipeline Drugs market: Global Outlook, Key Developments, And Market Share Analysis | 2022-26

May 31, 2022

May 31^ST,2022/IndustryNewsGlobal/ -- This new report from Stratview Research analyses the CINV Existing and Pipeline Drugs Market over the trend period from 2014 to 2019 and forecast period from 2022 to 2026. The insights of the report shall enable informed decision making and strategy formulation for the near future to capitalize on the opportunities.

CINV Existing and Pipeline Drugs Market Overview:

The sudden outbreak of the COVID-19 has led to unforeseen fluctuations across many industries and the CINV Existing and Pipeline Drugs Market is no different. Derived from the previous market scenario, the CINV Existing and Pipeline Drugs Market is likely to witness an impressive CAGR of 5.9% during the forecast period but with the global crisis in action, the growth curve has deviated from its expected path and exhibits an uncertain trajectory at present. 

Key Players:

• GlaxoSmithKline (UK)
• Helsinn (Switzerland)
• Heron Therapeutics (US)
• Merck (Germany)
• Tesaro (US)
• Eastman (US)
• Lonza (Switzerland)
• CHEMIDEA CHEMICALS (China)
• Teva pharmaceutical (Israel)
• Baxter Healthcare (US)

The CINV Existing and Pipeline Drugs Market is segmented by–

• By Drug Type (Akynzeo (netupitant-palonosetron), Emend (aprepitant), Aloxi (palonosetron), Zofran Generic (ondansetron), Kytril Generic (granisetron), SUSTOL (extended release granisetron injection), Rolapitant)
• By End-Use (Hospitals, Specialty Clinics, Diagnostic Centers Therapeutics, Hospital Pharmacies, Drugstores), and 
• Region- COVID-19 Impact Analysis and Forecast to 2026.

Get access to a deeper coverage of the impact of COVID-19 on this Market here: https://www.stratviewresearch.com/Request-Sample/2565/CINV-Existing-and-Pipeline-Drugs-Market.html#form

Regional analysis:

By region, the North American CINV Existing and Pipeline Drugs market accounted for the largest share in 2020 and is expected to grow at a significant CAGR during the review period. The CINV Existing and Pipeline Drugs market growth can be ascribed to a large presence of leading biotechnology companies, easy approval of CINV drugs, highly developed healthcare & research infrastructure, strong focus on drug discovery, and rising cancer cases in the region.

About Stratview Research

Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.

For enquiries,
Contact:
Stratview Research
E-mail: sales@stratviewresearch.com
Direct: +1-313-307-4176

Author : Emily